Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sihuan Pharmaceutical Hldgs (460 HK)
Watchlist
44
Analysis
Health Care
•
China
Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Traditional Chinese Medicine
•
21 Feb 2024 23:19
China Traditional Chinese Medicine (570 HK): Sinopharm-Led Pre-Conditional Offer at HK$4.60
The offer is attractive to historical trading ranges and peer multiples. Ping An, which holds a blocking stake, will be supportive. This looks like...
Arun George
Follow
422 Views
Share
bullish
•
China Traditional Chinese Medicine
•
07 Feb 2024 22:14
China Traditional Chinese Med (570 HK): Third Time's the Charm as Sinopharm Revives Its Interest?
Due to Sinopharm's previous privatisation attempts, shareholders will be wary of the latest rumour. Nevertheless, the valuation is undemanding...
Arun George
Follow
328 Views
Share
bearish
•
The United Laboratories International Holdings Limited
•
19 Sep 2023 12:21
United Laboratories International Holdings Placement (3933.HK) - Valuation Pullback Seems Inevitable
United Lab is facing a performance decline when the dividend period of the pandemic has subsided. Weight management/veterinary drug businesses have...
Xinyao (Criss) Wang
Follow
433 Views
Share
bearish
•
Shanghai Haohai Biological Technology
•
10 Feb 2023 08:55
Shanghai Haohai Biological Technology (688366.CH/6826.HK)- Disappointing Earnings and Gloomy Outlook
Continuous M&A fails to bring ideal performance to Haohai. Medical aesthetics is the main growth driver, but Haohai is lack of competitiveness....
Xinyao (Criss) Wang
Follow
286 Views
Share
bearish
•
Sihuan Pharmaceutical Hldgs
•
29 Nov 2022 08:45
Sihuan Pharmaceutical (460.HK) - About the Recent Business Adjustments and the Outlook
Sihuan's pursuing strategic adjustments actively, but its business transformation may not end up well without persuasive long logic. We recommend...
Xinyao (Criss) Wang
Follow
274 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.28.3
x